TY  - GEN
AU  - Mestre-Ferrándiz, Jorge
AU  - Iniesta, Margarita
AU  - Trapero-Bertran, Marta
AU  - Espín, Jaime
AU  - Brosa, Max
PY  - 2019
DO  - 10.1016/j.gaceta.2019.02.008
SN  - 0213-9111
UR  - http://hdl.handle.net/10668/3451
T2  - Gaceta Sanitaria
AB  - Objetivo Evaluar el acceso al mercado de los medicamentos huérfanos en España que a fecha de 31 de diciembre de 2017 tuvieran vigente su designación, y para aquellos comercializados en España estimar los tiempos entre la asignación de código nacional...
AB  - Objective To assess the access to orphan medicines in Spain, focusing on those with an active “orphan” designation, as of 31st December 2017; and for those orphan medicines in the Spanish market, estimate the time between being assigned a National...
LA  - spa
PB  - SESPAS. Editor comercial: Elsevier España, S.L.U.
KW  - Medicamentos huérfanos
KW  - Enfermedades raras
KW  - Autorización de comercialización
KW  - Acceso
KW  - Financiación
KW  - Orphan medicines
KW  - Rare diseases
KW  - Marketing authorisation
KW  - Access
KW  - Reimbursement
KW  - Medical Subject Headings::Technology and Food and Beverages::Technology, Industry, and Agriculture::Commerce
KW  - Medical Subject Headings::Geographical Locations::Geographic Locations::Europe
KW  - Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
KW  - Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Rare Diseases
KW  - Medical Subject Headings::Geographical Locations::Geographic Locations::Europe::Spain
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Evaluation Studies as Topic::Drug Approval
KW  - Medical Subject Headings::Health Care::Health Services Administration::Patient Care Management::Delivery of Health Care::Health Services Accessibility
KW  - Medical Subject Headings::Technology and Food and Beverages::Technology, Industry, and Agriculture::Industry::Drug Industry::Orphan Drug Production
TI  - Análisis de la evolución en el acceso a los medicamentos huérfanos en España
TY  - editorial
ER  -